Korea Investment CORP Takes Position in The Cooper Companies, Inc. $COO

Korea Investment CORP bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, Holdings Channel.com reports. The fund bought 155,395 shares of the medical device company’s stock, valued at approximately $11,143,000.

Other large investors also recently modified their holdings of the company. Avalon Trust Co acquired a new stake in Cooper Companies in the 2nd quarter valued at $25,000. Root Financial Partners LLC raised its holdings in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the last quarter. SJS Investment Consulting Inc. raised its holdings in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares during the last quarter. Elevation Wealth Partners LLC lifted its stake in shares of Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after buying an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp bought a new position in shares of Cooper Companies in the second quarter valued at $32,000. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on COO shares. Stifel Nicolaus decreased their target price on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Needham & Company LLC lowered their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Finally, UBS Group began coverage on Cooper Companies in a report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $81.64.

Cooper Companies Stock Down 0.6%

COO opened at $75.80 on Tuesday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company’s 50-day moving average is $72.09 and its 200 day moving average is $71.07. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The firm has a market capitalization of $14.78 billion, a P/E ratio of 64.24, a PEG ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.